Shanghai Pharmaceuticals | Sustainability Performance
Manufactures, distributes, and markets pharmaceutical products.
1994
China
10,001+ employees
Pharmaceuticals
$10B+ in revenue
$500M - 1B in profitability
Submit or report inaccurate dataDownload Company InsightsⓘBy downloading this report, you'll receive the most insightful and detailed analysis of the company's sustainability performance, compared to its peers. It includes key industry trends, carbon and energy intensity, nature impact, social metrics, and an in-depth look at key risks and controversies.
Sustainability Ranking & Industry Benchmark
#6462
Overallⓘ#324
in Chinaⓘ#155
in PharmaceuticalsⓘSustainability Maturity
ⓘSustainability Intent
ⓘOverview
Environmental
Carbon emissionsEnergy consumptionWaste ManagementWater ManagementAir & land impactNature and biodiversitySocial
Diversity and InclusionPay GapsHealth and SafetyExternalitiesGovernance
SDG ImpactFinancial Data
Business performanceCapital & innovationAnalyst projections
Aligned
Aligned
Aligned
Critical
Intensity
Greenhouse gas intensity Scope 1, 2 (tCO₂e /$M)
Water consumption intensity (m³ /$M)
Waste generation intensity (tonnes /$M)
Industry Benchmark
9.6
B/M 22.4
113.0
B/M 131.1
1.1
B/M 0.4
Powered by illuminem and GIST Impact
Controversy level
- Shanghai Pharmaceuticals Holding Co Ltd, Chinese statecontrolled pharmaceutical major, has faced sustained Chinese NMPA enforcement scrutiny over alleged inadequate disclosure of pharmaceutical distribution practices, plus periodic Chinese CSRC enforcement scrutiny on inadequate disclosure of pharmaceutical customer concentration affecting Shanghai municipal statecontrolled institutional minority shareholders.
